Cargando…
Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy
Fabry Disease (FD) is a systemic disorder that can result in cardiovascular, renal, and neurovascular disease leading to reduced life expectancy. FD should be considered in the differential of all patients with unexplained left ventricular hypertrophy (LVH). We therefore performed a prospective scre...
Autores principales: | Sadasivan, Chandu, Chow, Josie T. Y., Sheng, Bun, Chan, David K. H., Fan, Yiting, Choi, Paul C. L., Wong, Jeffrey K. T., Tong, Mabel M. B., Chan, Tsz-Ngai, Fung, Erik, Kam, Kevin K. H., Chan, Joseph Y. S., Chi, Wai-Kin, Paterson, D. Ian, Senaratne, Manohara, Brass, Neil, Oudit, Gavin Y., Lee, Alex P. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521938/ https://www.ncbi.nlm.nih.gov/pubmed/32987398 http://dx.doi.org/10.1371/journal.pone.0239675 |
Ejemplares similares
-
High Prevalence of Late-Onset Fabry Cardiomyopathy in a Cohort of 499 Non-Selective Patients with Left Ventricular Hypertrophy: The Asian Fabry Cardiomyopathy High-Risk Screening Study (ASIAN-FAME)
por: Fan, Yiting, et al.
Publicado: (2021) -
Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic
por: Gagnon, Luke R., et al.
Publicado: (2022) -
Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications
por: Zhabyeyev, Pavel, et al.
Publicado: (2023) -
Unexplained Left Ventricular Hypertrophy Diagnosed as a Cardiac Variant of Late-Onset Fabry Disease: A Case Report
por: Zhao, Maomao, et al.
Publicado: (2023) -
Reduced native right ventricular T(1 )in Anderson-Fabry disease as compared to patients with pulmonary hypertension
por: Pagano, Joseph J, et al.
Publicado: (2014)